Advocacy group accuses Novo Nordisk of violating FDA's 'fair balance' advertising rules
A nonprofit advocacy group has filed a complaint with the FDA accusing Novo Nordisk of lining up promotional material for its weight loss drug Wegovy that masqueraded as a CBS news segment.
The complaint filed by the Physicians Committee for Responsible Medicine on Thursday takes issue with a 13-minute segment of a 60 Minutes episode that aired on Jan. 1, featuring two Boston-area doctors who’ve consulted for Novo Nordisk.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.